Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 50 of 221

    1.

    Human respiratory syncytial virus reduces the number of cells in S-phase and increases GADD153 expression in HEp-2 cells.

    Mohapatra S, Park SJ, Boyapalle S, Pastey MK, Graham BS, Blanck G.

    Acta Virol. 2009;53(3):207-11.PMID: 19953728 [PubMed - in process]

    2.

    What does the report of the USMHRP Phase III study in Thailand mean for HIV and for vaccine developers?

    Graham BS.

    Clin Exp Immunol. 2009 Dec;158(3):257-9. No abstract available. PMID: 19906099 [PubMed - in process]Related articles

    3.

    Differential specificity and immunogenicity of adenovirus 5 neutralizing antibodies elicited by natural infection or immunization.

    Cheng C, Gall JG, Nason M, King CR, Koup RA, Roederer M, McElrath MJ, Morgan CA, Churchyard G, Baden LR, Duerr AC, Keefer MC, Graham BS, Nabel GJ.

    J Virol. 2009 Oct 21. [Epub ahead of print]PMID: 19846512 [PubMed - as supplied by publisher]Related articles

    4.

    DNA vaccines: a safe and efficient platform technology for responding to emerging infectious diseases.

    Ledgerwood JE, Graham BS.

    Hum Vaccin. 2009 Sep;5(9):623-6. No abstract available. PMID: 19779298 [PubMed - in process]Related articles

    5.

    Vaccine development in the twenty-first century: changing paradigms for elusive viruses.

    Graham BS, Ledgerwood JE, Nabel GJ.

    Clin Pharmacol Ther. 2009 Sep;86(3):234-6. No abstract available. PMID: 19707212 [PubMed - indexed for MEDLINE]Related articles

    6.

    TLR9 agonist, but not TLR7/8, functions as an adjuvant to diminish FI-RSV vaccine-enhanced disease, while either agonist used as therapy during primary RSV infection increases disease severity.

    Johnson TR, Rao S, Seder RA, Chen M, Graham BS.

    Vaccine. 2009 May 18;27(23):3045-52. Epub 2009 Apr 3.PMID: 19428918 [PubMed - indexed for MEDLINE]Related articles

    7.

    Correlates of protective immunity for Ebola vaccines: implications for regulatory approval by the animal rule.

    Sullivan NJ, Martin JE, Graham BS, Nabel GJ.

    Nat Rev Microbiol. 2009 May;7(5):393-400. Review. Erratum in: Nat Rev Microbiol. 2009 Sep;7(9):684. PMID: 19369954 [PubMed - indexed for MEDLINE]Related articles

    8.

    Replication-defective adenovirus vectors with multiple deletions do not induce measurable vector-specific T cells in human trials.

    Koup RA, Lamoreaux L, Zarkowsky D, Bailer RT, King CR, Gall JG, Brough DE, Graham BS, Roederer M.

    J Virol. 2009 Jun;83(12):6318-22. Epub 2009 Apr 1.PMID: 19339347 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    High titer HIV-1 V3-specific antibodies with broad reactivity but low neutralizing potency in acute infection and following vaccination.

    Davis KL, Gray ES, Moore PL, Decker JM, Salomon A, Montefiori DC, Graham BS, Keefer MC, Pinter A, Morris L, Hahn BH, Shaw GM.

    Virology. 2009 May 10;387(2):414-26. Epub 2009 Mar 18.PMID: 19298995 [PubMed - indexed for MEDLINE]Related articles

    10.

    Characterization of respiratory syncytial virus M- and M2-specific CD4 T cells in a murine model.

    Liu J, Ruckwardt TJ, Chen M, Johnson TR, Graham BS.

    J Virol. 2009 May;83(10):4934-41. Epub 2009 Mar 4.PMID: 19264776 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    Evidence of prior exposure to human bocavirus as determined by a retrospective serological study of 404 serum samples from adults in the United States.

    Cecchini S, Negrete A, Virag T, Graham BS, Cohen JI, Kotin RM.

    Clin Vaccine Immunol. 2009 May;16(5):597-604. Epub 2009 Feb 25.PMID: 19244471 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    Regulatory T cells promote early influx of CD8+ T cells in the lungs of respiratory syncytial virus-infected mice and diminish immunodominance disparities.

    Ruckwardt TJ, Bonaparte KL, Nason MC, Graham BS.

    J Virol. 2009 Apr;83(7):3019-28. Epub 2009 Jan 19.PMID: 19153229 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    A SARS DNA vaccine induces neutralizing antibody and cellular immune responses in healthy adults in a Phase I clinical trial.

    Martin JE, Louder MK, Holman LA, Gordon IJ, Enama ME, Larkin BD, Andrews CA, Vogel L, Koup RA, Roederer M, Bailer RT, Gomez PL, Nason M, Mascola JR, Nabel GJ, Graham BS; VRC 301 Study Team.

    Vaccine. 2008 Nov 25;26(50):6338-43. Epub 2008 Sep 26.PMID: 18824060 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    Pulmonary eosinophilia requires interleukin-5, eotaxin-1, and CD4+ T cells in mice immunized with respiratory syncytial virus G glycoprotein.

    Johnson TR, Rothenberg ME, Graham BS.

    J Leukoc Biol. 2008 Sep;84(3):748-59. Epub 2008 Jun 2.PMID: 18519743 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    Reply to rottinghaus and poland.

    Martin JE, Pierson TC, Graham BS.

    J Infect Dis. 2008 Jun 1;197(11):1628-9. No abstract available. PMID: 18471067 [PubMed - as supplied by publisher]Related articles

    16.

    Maturation of West Nile virus modulates sensitivity to antibody-mediated neutralization.

    Nelson S, Jost CA, Xu Q, Ess J, Martin JE, Oliphant T, Whitehead SS, Durbin AP, Graham BS, Diamond MS, Pierson TC.

    PLoS Pathog. 2008 May 9;4(5):e1000060.PMID: 18464894 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    A filovirus-unique region of Ebola virus nucleoprotein confers aberrant migration and mediates its incorporation into virions.

    Shi W, Huang Y, Sutton-Smith M, Tissot B, Panico M, Morris HR, Dell A, Haslam SM, Boyington J, Graham BS, Yang ZY, Nabel GJ.

    J Virol. 2008 Jul;82(13):6190-9. Epub 2008 Apr 16.PMID: 18417588 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    A West Nile virus DNA vaccine induces neutralizing antibody in healthy adults during a phase 1 clinical trial.

    Martin JE, Pierson TC, Hubka S, Rucker S, Gordon IJ, Enama ME, Andrews CA, Xu Q, Davis BS, Nason M, Fay M, Koup RA, Roederer M, Bailer RT, Gomez PL, Mascola JR, Chang GJ, Nabel GJ, Graham BS.

    J Infect Dis. 2007 Dec 15;196(12):1732-40.PMID: 18190252 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    Viral and host factors in human respiratory syncytial virus pathogenesis.

    Collins PL, Graham BS.

    J Virol. 2008 Mar;82(5):2040-55. Epub 2007 Oct 10. Review. No abstract available. PMID: 17928346 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    Induction of HIV-specific functional immune responses by a multiclade HIV-1 DNA vaccine candidate in healthy Ugandans.

    Eller MA, Eller LA, Opollo MS, Ouma BJ, Oballah PO, Galley L, Karnasuta C, Kim SR, Robb ML, Michael NL, Kibuuka H, Wabwire-Mangen F, Graham BS, Birx DL, de Souza MS, Cox JH.

    Vaccine. 2007 Nov 7;25(45):7737-42. Epub 2007 Sep 17.PMID: 17920731 [PubMed - indexed for MEDLINE]Related articles

    21.

    UIC is prepared for the future.

    Graham BS.

    CDS Rev. 2007 May-Jun;100(3):6. No abstract available. PMID: 17555010 [PubMed - indexed for MEDLINE]Related articles

    22.

    Immunization with vaccinia virus induces polyfunctional and phenotypically distinctive CD8(+) T cell responses.

    Precopio ML, Betts MR, Parrino J, Price DA, Gostick E, Ambrozak DR, Asher TE, Douek DC, Harari A, Pantaleo G, Bailer R, Graham BS, Roederer M, Koup RA.

    J Exp Med. 2007 Jun 11;204(6):1405-16. Epub 2007 May 29.PMID: 17535971 [PubMed - indexed for MEDLINE]Related articlesFree article

    23.

    Phase I clinical evaluation of a six-plasmid multiclade HIV-1 DNA candidate vaccine.

    Catanzaro AT, Roederer M, Koup RA, Bailer RT, Enama ME, Nason MC, Martin JE, Rucker S, Andrews CA, Gomez PL, Mascola JR, Nabel GJ, Graham BS; VRC 007 Study Team.

    Vaccine. 2007 May 16;25(20):4085-92. Epub 2007 Mar 7.PMID: 17391815 [PubMed - indexed for MEDLINE]Related articles

    24.

    Safety and immunogenicity of a Gag-Pol candidate HIV-1 DNA vaccine administered by a needle-free device in HIV-1-seronegative subjects.

    Tavel JA, Martin JE, Kelly GG, Enama ME, Shen JM, Gomez PL, Andrews CA, Koup RA, Bailer RT, Stein JA, Roederer M, Nabel GJ, Graham BS.

    J Acquir Immune Defic Syndr. 2007 Apr 15;44(5):601-5.PMID: 17325604 [PubMed - indexed for MEDLINE]Related articlesFree article

    25.

    Relative dominance of epitope-specific CD8+ T cell responses in an F1 hybrid mouse model of respiratory syncytial virus infection.

    Rutigliano JA, Ruckwardt TJ, Martin JE, Graham BS.

    Virology. 2007 Jun 5;362(2):314-9. Epub 2007 Feb 2.PMID: 17275872 [PubMed - indexed for MEDLINE]Related articlesFree article

    26.

    Smallpox vaccines: Past, present, and future.

    Parrino J, Graham BS.

    J Allergy Clin Immunol. 2006 Dec;118(6):1320-6. Review.PMID: 17157663 [PubMed - indexed for MEDLINE]Related articles

    27.

    The histopathology of fatal untreated human respiratory syncytial virus infection.

    Johnson JE, Gonzales RA, Olson SJ, Wright PF, Graham BS.

    Mod Pathol. 2007 Jan;20(1):108-19. Epub 2006 Nov 24.PMID: 17143259 [PubMed - indexed for MEDLINE]Related articlesFree article

    28.

    Safety, immunogenicity and efficacy of modified vaccinia Ankara (MVA) against Dryvax challenge in vaccinia-naïve and vaccinia-immune individuals.

    Parrino J, McCurdy LH, Larkin BD, Gordon IJ, Rucker SE, Enama ME, Koup RA, Roederer M, Bailer RT, Moodie Z, Gu L, Yan L, Graham BS; VRC 201/203 Study Team.

    Vaccine. 2007 Feb 9;25(8):1513-25. Epub 2006 Nov 7.PMID: 17126963 [PubMed - indexed for MEDLINE]Related articlesFree article

    29.

    IL-13 is associated with reduced illness and replication in primary respiratory syncytial virus infection in the mouse.

    Zhou W, Hashimoto K, Moore ML, Elias JA, Zhu Z, Durbin J, Colasurdo G, Rutigliano JA, Chiappetta CL, Goleniewska K, O'Neal JF, Graham BS, Peebles RS Jr.

    Microbes Infect. 2006 Nov-Dec;8(14-15):2880-9. Epub 2006 Oct 24.PMID: 17110149 [PubMed - indexed for MEDLINE]Related articlesFree article

    30.

    Phase 1 safety and immunogenicity evaluation of a multiclade HIV-1 DNA candidate vaccine.

    Graham BS, Koup RA, Roederer M, Bailer RT, Enama ME, Moodie Z, Martin JE, McCluskey MM, Chakrabarti BK, Lamoreaux L, Andrews CA, Gomez PL, Mascola JR, Nabel GJ; Vaccine Research Center 004 Study Team.

    J Infect Dis. 2006 Dec 15;194(12):1650-60. Epub 2006 Nov 8.PMID: 17109336 [PubMed - indexed for MEDLINE]Related articlesFree article

    31.

    Phase 1 safety and immunogenicity evaluation of a multiclade HIV-1 candidate vaccine delivered by a replication-defective recombinant adenovirus vector.

    Catanzaro AT, Koup RA, Roederer M, Bailer RT, Enama ME, Moodie Z, Gu L, Martin JE, Novik L, Chakrabarti BK, Butman BT, Gall JG, King CR, Andrews CA, Sheets R, Gomez PL, Mascola JR, Nabel GJ, Graham BS; Vaccine Research Center 006 Study Team.

    J Infect Dis. 2006 Dec 15;194(12):1638-49. Epub 2006 Nov 8. Erratum in: J Infect Dis. 2009 Oct 15;200(8):1352-3. PMID: 17109335 [PubMed - indexed for MEDLINE]Related articlesFree article

    32.

    Phase 2 study of an HIV-1 canarypox vaccine (vCP1452) alone and in combination with rgp120: negative results fail to trigger a phase 3 correlates trial.

    Russell ND, Graham BS, Keefer MC, McElrath MJ, Self SG, Weinhold KJ, Montefiori DC, Ferrari G, Horton H, Tomaras GD, Gurunathan S, Baglyos L, Frey SE, Mulligan MJ, Harro CD, Buchbinder SP, Baden LR, Blattner WA, Koblin BA, Corey L; National Institute of Allergy and Infectious Diseases HIV Vaccine Trials Network.

    J Acquir Immune Defic Syndr. 2007 Feb 1;44(2):203-12.PMID: 17106277 [PubMed - indexed for MEDLINE]Related articlesFree article

    33.

    Educating dental students about oral health care access disparities.

    Graham BS.

    J Dent Educ. 2006 Nov;70(11):1208-11.PMID: 17106036 [PubMed - indexed for MEDLINE]Related articlesFree article

    34.

    Folliculitis decalvans treated with radiation therapy.

    Smith EP, Hardaway CA, Graham BS, Johnstone PA.

    Cutis. 2006 Sep;78(3):162-4.PMID: 17036658 [PubMed - indexed for MEDLINE]Related articles

    35.

    Novel approach for differential diagnosis of HIV infections in the face of vaccine-generated antibodies: utility for detection of diverse HIV-1 subtypes.

    Khurana S, Needham J, Park S, Mathieson B, Busch MP, Nemo G, Nyambi P, Zolla-Pazner S, Laal S, Mulenga J, Chomba E, Hunter E, Allen S, McIntyre J, Hewlett I, Lee S, Tang S, Cowan E, Beyrer C, Altfeld M, Yu XG, Tounkara A, Koita O, Kamali A, Nguyen N, Graham BS, Todd D, Mugenyi P, Anzala O, Sanders E, Ketter N, Fast P, Golding H.

    J Acquir Immune Defic Syndr. 2006 Nov 1;43(3):304-12.PMID: 17019363 [PubMed - indexed for MEDLINE]Related articlesFree article

    36.

    A DNA vaccine for Ebola virus is safe and immunogenic in a phase I clinical trial.

    Martin JE, Sullivan NJ, Enama ME, Gordon IJ, Roederer M, Koup RA, Bailer RT, Chakrabarti BK, Bailey MA, Gomez PL, Andrews CA, Moodie Z, Gu L, Stein JA, Nabel GJ, Graham BS.

    Clin Vaccine Immunol. 2006 Nov;13(11):1267-77. Epub 2006 Sep 20.PMID: 16988008 [PubMed - indexed for MEDLINE]Related articlesFree article

    37.

    Subunit recombinant vaccine protects against monkeypox.

    Heraud JM, Edghill-Smith Y, Ayala V, Kalisz I, Parrino J, Kalyanaraman VS, Manischewitz J, King LR, Hryniewicz A, Trindade CJ, Hassett M, Tsai WP, Venzon D, Nalca A, Vaccari M, Silvera P, Bray M, Graham BS, Golding H, Hooper JW, Franchini G.

    J Immunol. 2006 Aug 15;177(4):2552-64.PMID: 16888017 [PubMed - indexed for MEDLINE]Related articlesFree article

    38.

    Human immunodeficiency virus (HIV) vaccine trials: a novel assay for differential diagnosis of HIV infections in the face of vaccine-generated antibodies.

    Khurana S, Needham J, Mathieson B, Rodriguez-Chavez IR, Catanzaro AT, Bailer RT, Kim J, Polonis V, Cooper DA, Guerin J, Peterson ML, Gurwith M, Nguyen N, Graham BS, Golding H.

    J Virol. 2006 Mar;80(5):2092-9.PMID: 16474117 [PubMed - indexed for MEDLINE]Related articlesFree article

    39.

    New approaches to vaccine adjuvants: inhibiting the inhibitor.

    Graham BS.

    PLoS Med. 2006 Jan;3(1):e57. Epub 2006 Jan 3. No abstract available. PMID: 16383350 [PubMed - indexed for MEDLINE]Related articlesFree article

    40.

    Allergen-induced airway hyperresponsiveness mediated by cyclooxygenase inhibition is not dependent on 5-lipoxygenase or IL-5, but is IL-13 dependent.

    Peebles RS Jr, Hashimoto K, Sheller JR, Moore ML, Morrow JD, Ji S, Elias JA, Goleniewska K, O'neal J, Mitchell DB, Graham BS, Zhou W.

    J Immunol. 2005 Dec 15;175(12):8253-9.PMID: 16339565 [PubMed - indexed for MEDLINE]Related articlesFree article

    41.

    Eruptive syringomas: an unusual presentation on the buttocks.

    Powell CL, Smith EP, Graham BS.

    Cutis. 2005 Oct;76(4):267-9. Review.PMID: 16315564 [PubMed - indexed for MEDLINE]Related articles

    42.

    Primary cutaneous blastic natural killer cell lymphoma.

    Parlette EC, Elliott JZ, Hall FW, Graham BS.

    J Am Acad Dermatol. 2005 Oct;53(4):742-3. No abstract available. PMID: 16198814 [PubMed - indexed for MEDLINE]Related articles

    43.

    Respiratory syncytial virus infection in the absence of STAT 1 results in airway dysfunction, airway mucus, and augmented IL-17 levels.

    Hashimoto K, Durbin JE, Zhou W, Collins RD, Ho SB, Kolls JK, Dubin PJ, Sheller JR, Goleniewska K, O'Neal JF, Olson SJ, Mitchell D, Graham BS, Peebles RS Jr.

    J Allergy Clin Immunol. 2005 Sep;116(3):550-7.PMID: 16159623 [PubMed - indexed for MEDLINE]Related articles

    44.

    Dental education in crisis.

    Graham BS.

    CDS Rev. 2005 May-Jun;98(3):6. No abstract available. PMID: 16130310 [PubMed - indexed for MEDLINE]Related articles

    45.

    Pathogenesis of respiratory syncytial virus infection in the murine model.

    Peebles RS Jr, Graham BS.

    Proc Am Thorac Soc. 2005;2(2):110-5. Review.PMID: 16113477 [PubMed - indexed for MEDLINE]Related articlesFree article

    46.

    Is dentistry a business or a profession?

    Graham BS.

    J Am Coll Dent. 2004 Winter;71(4):8-10. No abstract available. PMID: 15948486 [PubMed - indexed for MEDLINE]Related articles

    47.

    Identification of an H-2D(b)-restricted CD8+ cytotoxic T lymphocyte epitope in the matrix protein of respiratory syncytial virus.

    Rutigliano JA, Rock MT, Johnson AK, Crowe JE Jr, Graham BS.

    Virology. 2005 Jul 5;337(2):335-43.PMID: 15916793 [PubMed - indexed for MEDLINE]Related articles

    48.

    Exogenous and endogenous cutaneous anomalies and curiosities.

    Del Rosario RN, Barr RJ, Graham BS, Kaneshiro S.

    Am J Dermatopathol. 2005 Jun;27(3):259-67. Review.PMID: 15900135 [PubMed - indexed for MEDLINE]Related articles

    49.

    Necrotic ulcer on the thumb of a teenager with leukemia.

    O'Neill JT, Blair M, Graham BS.

    Arch Dermatol. 2005 May;141(5):633-8. No abstract available. PMID: 15897391 [PubMed - indexed for MEDLINE]Related articles

    50.

    RhoA signaling is required for respiratory syncytial virus-induced syncytium formation and filamentous virion morphology.

    Gower TL, Pastey MK, Peeples ME, Collins PL, McCurdy LH, Hart TK, Guth A, Johnson TR, Graham BS.

    J Virol. 2005 May;79(9):5326-36.PMID: 15827147 [PubMed - indexed for MEDLINE]Related articlesFree article

    Display Settings:

    Format
    Items per page
    Sort by

    Send to:

    Choose Destination

    Supplemental Content

    Find related data

    Search details

    » See more...